Skip to main content
. 2021 Dec 28;14(1):128. doi: 10.3390/cancers14010128

Table 2.

Characteristics of HIV-cHL patients with matched controls at cHL diagnosis.

Populations p-Values *
cHL Patients (n = 14) Controls (n = 14)
Age 0.0006
Median 46 51
IQR 41–52 44–55
Sex 1
M 12 12
F 2 2
HIV viral Load (copies/mL) 1
≤200 13 12
>200 1 2
Serum Markers
IgG levels (g/L) 0.31
Median 13.2 13.3
IQR 12.1–16.5 10.1–15.6
n 14 14
IgA levels (g/L) 0.19
Median 3.2 2.2
IQR 1.6–4.0 1.7–2.6
n 14 14
IgM levels (g/L) 0.49
Median 0.8 0.6
IQR 0.5–1.1 0.4–1.0
n 14 14
IL10 (pg/mL) <0.0001
Median 22.4 4.5
IQR 11.2–54.4 3.9–7.5
n 14 14
IL6 (pg/mL) 0.002
Median 23.5 2.1
IQR 5.2–128.7 0.9–9
n 14 14
BAFF (pg/mL) <0.0001
Median 898.9 398.8
IQR 720.2–1790.3 323.2–445.4
n 14 14
Lymphocytic subpopulations
CD45+ Lymphocytes 0.63
(cells/μL) Median 1488 1629
IQR 966–2570 1203–2086
n 14 14
CD3+CD4+ T-cells 0.39
(cells/μL) Median 498.5 417.5
IQR 328–579 386–558
n 14 14
CD3+CD8+ T-cells 0.33
(cells/μL) Median 616.5 646.5
IQR 415–1208 431–741
n 14 14
CD19+ B-cells 0.91
(cells/μL) Median 165 170.5
IQR 87–210 125–222
n 14 14
%CD27IgD+ CD19+ naive B-cells 0.0005
Median 76.2 53.1
IQR 64.7–89.1 38.3–62.2
n 12 12
%CD27+IgD+ in CD19+ marginal zone-type B-cells 0.62
Median 5.5 11.5
IQR 4.1–20.5 5.6–14.1
n 12 12
%CD27+IgD in CD19+ memory B-cells 0.0005
Median 6.7 25.2
IQR 1.8–11.5 20.5–32.2
n 12 12
CD56+CD16+ NK-cells 0.17
(cells/μL) Median 143.5 247.5
IQR 81–258 125–406
n 14 14

* p values were determined by the McNemar test (categorical variables) or the Wilcoxon signed-rank test (continuous variables). cHL: classical Hodgkin lymphoma; IQR: interquartile range; NK: natural killer.